High incidence of multiresistant bacterial isolates from bloodstream infections in trauma emergency department and intensive care unit in Serbia

Acta Microbiologica Et Immunologica Hungarica
Olivera DjuricVesna Bumbasirevic

Abstract

We investigated the incidence of bloodstream infections (BSIs) in trauma emergency department (ED) and intensive care unit (ICU), to assess ED- and ICU-related predictors of BSI and to describe the most common bacteria causing BSI and their antimicrobial resistance markers. A prospective study was conducted in two trauma ICUs of the ED of Clinical Center of Serbia. Overall, 62 BSIs were diagnosed in 406 patients, of which 13 were catheter-related BSI (3.0/1,000 CVC-days) and 30 BSIs of unknown origin, while 15% were attributed to ED CVC exposure. Lactate ≥2 mmol/L and SOFA score were independent ED-related predictors of BSI, while CVC in place for >7 days and mechanical ventilation >7 days were significant ICU-related predictors. The most common bacteria recovered were Acinetobacter spp., Klebsiella spp., and Pseudomonas aeruginosa. All Staphylococcus aureus and coagulase-negative staphylococci isolates were methicillin-resistant, whereas 66% of Enterococcus spp. were vancomycin-resistant. All isolates of Enterobacteriaceae were resistant to third-generation cephalosporins, whereas 87.5% of P. aeruginosa and 95.8% of Acinetobacter spp. isolates were resistant to carbapenems. ED BSI contributes substantially to overall ICU incid...Continue Reading

References

Apr 1, 1997·American Journal of Infection Control·T C Horan, T G Emori
Apr 11, 2001·Emerging Infectious Diseases·R GaynesJ Tolson
Aug 13, 2005·The Journal of Trauma·Harrison M LazarusMark H Stevens
Jul 13, 2007·The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases·Heloisa Ihle Garcia GiamberardinoRogério Andrade Mulinari
Jun 11, 2009·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Didier PittetUNKNOWN World Health Organization World Alliance for Patient Safety First Global Patient Safety Challenge Core Group of Experts
Oct 13, 2009·The Journal of Trauma·Angela S CzajaEllen Mackenzie
Apr 8, 2010·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Daniel A del PortalJesse M Pines
Sep 28, 2010·Annals of Emergency Medicine·Christopher H LeMasterPeter C Hou
Jun 12, 2012·The Journal of Surgical Research·Carla F JustinianoStanislaw P A Stawicki
Sep 11, 2012·Antimicrobial Resistance and Infection Control·Sonja HansenPetra Gastmeier
Mar 29, 2014·European Journal of Microbiology & Immunology·O LiesenfeldG Kost
Apr 4, 2014·Journal of Laboratory Physicians·Purva MathurMahesh C Misra
Sep 3, 2014·American Journal of Infection Control·Víctor Daniel RosenthalUNKNOWN International Nosocomial Infection Control Consortium
Sep 4, 2015·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Daniel TheodoroVictoria Fraser
Mar 6, 2016·American Journal of Infection Control·Sanwar M MitharwalLakshminarayana Yaddanapudi
Jun 16, 2016·Journal of Pain & Palliative Care Pharmacotherapy· Centers For Disease Control And Prevention Public Health Service U S Department Of Health And Human Services
Oct 22, 2016·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Lindsey M WeinerDawn M Sievert
Oct 17, 2017·The American Journal of Emergency Medicine·Bonny J BaronShahriar Zehtabchi

❮ Previous
Next ❯

Citations

Nov 13, 2021·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·Simon BrinkwirthRobby Markwart

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.